Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance.
about
How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis VaccinesHaemophilus influenzae acquires vitronectin via the ubiquitous Protein F to subvert host innate immunityPhase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage.Meningococcal outer membrane protein NhhA triggers apoptosis in macrophages.Meningococcal disease and the complement system.Opc expression, LPS immunotype switch and pilin conversion contribute to serum resistance of unencapsulated meningococci.A novel group of Moraxella catarrhalis UspA proteins mediates cellular adhesion via CEACAMs and vitronectin.Evaluation of truncated NhhA protein as a candidate meningococcal vaccine antigen.Identification and therapeutic potential of a vitronectin binding region of meningococcal msfPseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement AttackImpact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.Yersinia pestis uses the Ail outer membrane protein to recruit vitronectinZnuD, a potential candidate for a simple and universal Neisseria meningitidis vaccine.Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion.The biology of Neisseria adhesins.The Rickettsia conorii Adr1 Interacts with the C-Terminus of Human Vitronectin in a Salt-Sensitive Manner.Large scale genomic analysis shows no evidence for pathogen adaptation between the blood and cerebrospinal fluid niches during bacterial meningitis.Bacteria under stress by complement and coagulation.Immune Homeostatic Macrophages Programmed by the Bacterial Surface Protein NhhA Potentiate Nasopharyngeal Carriage of Neisseria meningitidis.Neisseria models of infection and persistence in the upper respiratory tract.Biological Functions of the Secretome of Neisseria meningitidisThe sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease.Moonlighting of Helicobacter pylori catalase protects against complement-mediated killing by utilising the host molecule vitronectin.Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.The meningococcal adhesin NhhA provokes proinflammatory responses in macrophages via toll-like receptor 4-dependent and -independent pathways.Comparative proteome analysis of spontaneous outer membrane vesicles and purified outer membranes of Neisseria meningitidis.Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design.
P2860
Q26782340-65A2E8F5-35FE-4C61-8666-CC782DDB6E18Q28285069-B6E47090-7BE3-493C-8757-D3786870B675Q33603065-5061E0FD-5DA1-4C7F-A36B-EA841006B3EDQ34125128-E3258E7F-28BF-4C05-B86D-5875C5970A5DQ34376170-DDBC4B02-2B30-4D89-9E92-C46981512FA3Q34428168-2A92429E-07DD-4BE6-9065-224ED1DFA11EQ34438142-6EE73F95-1D5A-4090-AEF4-3FA3D16122E2Q34988272-E581220B-9D04-4FAB-BC15-84A0D6C678FEQ35235006-8BBC0019-FDB1-42C3-9DF3-C66F83CAD580Q35774133-F9633319-535D-474A-9A6F-B3402A10482DQ35922195-3DCCDCB9-DCBA-49F9-B33B-95C017F6F40AQ36725574-4E03E563-A24F-4825-8AD0-194BA9C4679CQ36911374-4862EB8C-7DB2-47CE-9B52-B59AC223A827Q37516016-455C1690-02CC-499E-B7C9-5D7F5B2DD0CAQ37651436-DA58B9B9-4BFF-42BA-BE54-6AC72565E512Q37672403-A4985045-3FF4-41E2-84A4-7D171B9BEFA1Q37715414-306A2A4A-6949-44C5-9E60-5AC559965040Q38234314-B7C5633D-37D8-4EDB-A7CE-5B50408E32D2Q38404143-078A2223-6471-485F-B228-6B56E0655733Q38736135-EF6B2B62-2FDA-4F82-B492-5DCBFFAEA847Q39410503-CB8108C3-3AE3-4BAC-9085-1B213F298D43Q40165094-9ED97D08-6AD4-486C-82B6-2AA24A1F0A24Q40273799-DA0F2370-DD14-4F7C-AD1D-45452F433D6CQ40819035-E57F3E78-92A1-4174-8EFD-85A801534D75Q41585325-0DD909D3-BF90-4370-B5DD-3998384A4C00Q42935645-98F680D8-0B91-40B9-A5EF-48928EBC329FQ52352963-E98531F0-6185-4DDC-9CD6-875FEC5BD64B
P2860
Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Meningococcal surface fibril ( ...... to increase serum resistance.
@en
Meningococcal surface fibril
@nl
type
label
Meningococcal surface fibril ( ...... to increase serum resistance.
@en
Meningococcal surface fibril
@nl
prefLabel
Meningococcal surface fibril ( ...... to increase serum resistance.
@en
Meningococcal surface fibril
@nl
P2093
P2860
P1476
Meningococcal surface fibril ( ...... to increase serum resistance.
@en
P2093
Christiane M Feron
Darryl J Hill
Elena Borodina
Jan T Poolman
Mumtaz Virji
Natalie J Griffiths
Nathalie I Devos
Richard B Sessions
P2860
P304
P356
10.1111/J.1365-2958.2011.07876.X
P407
P577
2011-11-04T00:00:00Z